Page last updated: 2024-08-24

trofosfamide and Angiosarcoma

trofosfamide has been researched along with Angiosarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreesen, R; Bataille, F; Berand, A; Bross, K; Hafner, C; Jauch, KW; Landthaler, M; Reichle, A; Vogt, T	1
Hartmann, JT; Kanz, L; Kopp, HG	1

Trials

1 trial(s) available for trofosfamide and Angiosarcoma

Article	Year
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer, 2003, Nov-15, Volume: 98, Issue:10 Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Female; Hemangioendothelioma; Hemangiosarcoma; Humans; Lactones; Male; Middle Aged; Pioglitazone; Sulfones; Thiazolidinediones; Treatment Outcome	2003

Article

Year

Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.

Cancer, 2003, Nov-15, Volume: 98, Issue:10

Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Female; Hemangioendothelioma; Hemangiosarcoma; Humans; Lactones; Male; Middle Aged; Pioglitazone; Sulfones; Thiazolidinediones; Treatment Outcome

2003

Other Studies

1 other study(ies) available for trofosfamide and Angiosarcoma

Article	Year
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide. Anti-cancer drugs, 2006, Volume: 17, Issue:8 Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Hemangiosarcoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction	2006